TechCrunch

APRIL 6, 2022

As a venture firm that invests in psychedelics, we receive hundreds of pitches every month from founders developing psychedelic therapeutics. Our fund has invested more than $15 million in companies developing psychedelic therapeutics. The most important factor that can make or break a psychedelic biotech company is its team.

Biotech 246

Biotech Company Pharmaceuticals Healthcare 246

Crunchbase News

JANUARY 6, 2025

Although 2024 was another exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025 after its three-year lull. With that in mind, here are 13 companies that the Crunchbase News team thinks could be top contenders to go public if our 2025 market forecast bears out. That made sense.

Marketing 129

Marketing Company Technical Review Fintech 129

TechCrunch

FEBRUARY 28, 2022

Stämm Biotech , founded in 2014, is developing a desktop-sized bioreactor that looks pretty different from the tanks, tubes and knobs traditionally seen in industrial or even benchtop bioreactors. Instead, it’s developing a unit that 3D prints a dense network of microchannels that pass cells through the nutrients and oxygen they need.

Biotech 226

Biotech 3D Chemicals Industry 226

TechCrunch

OCTOBER 27, 2020

Biotech can often, and sometimes literally, fly over our heads. For IndieBio, a science and biotech accelerator run by VC firm SOSV, this unprecedented year offered high stakes and new challenges. Today and tomorrow, the biotech accelerator is hosting its twice-annual demo day. Image Credits: Witthaya Prasongsin / Getty Images.

Biotech 230

Biotech Meeting Sustainability Chemicals 230

TechCrunch

DECEMBER 16, 2022

“While it may feel counterintuitive, given the recent market environment, the value of the equity for all parties — investors, founders and employees — is higher in the more conservative growth scenario,” says Mitchem. 6 investors discuss why AI is more than just a buzzword in biotech. Target audience/market size slide.

Case Study 215

Case Study Biotech Survey Study 215

N2Growth Blog

OCTOBER 23, 2023

Additionally, the industry’s highly regulated nature means that executives must have a keen eye for compliance and a strong ability to navigate the ever-changing market dynamics. Top executive search firms also bring a unique set of resources and expertise to the table when it comes to attracting top talent for biotech companies.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

TechCrunch

MARCH 21, 2023

When you think of life sciences and biotech hubs in the U.S., Portal Innovations , a biotech VC firm based in Chicago, is trying to broaden everyone’s horizons and give opportunities to biotech startups growing out of labs in Chicago, Atlanta, and hopefully beyond. As AI pervades biotech, what are investors looking for in 2023?

Biotech 203

Biotech Development Team Review Technical Review Innovation 203

TechCrunch

APRIL 8, 2022

. “Gogoro will use the fresh funds from its IPO to continue to expand in Taiwan as it branches outward to larger markets like China, India and Indonesia,” writes transportation reporter Rebecca Bellan. 6 questions investors should ask when evaluating psychedelic biotech companies. How can we support them?

Biotech 222

Biotech Windows Transportation Travel 222

Crunchbase News

FEBRUARY 19, 2025

Even so, investment remains below the heights scaled during the 2021 market peak. billion globally went to companies applying advances in artificial intelligence to health-related areas such as medical services and pharmaceutical development, per Crunchbase data. Last year, more than $7.5 billion already invested.

Healthcare 115

Healthcare Artificial Inteligence Biotech Artificial Intelligence 115

Crunchbase News

JANUARY 10, 2025

By Caleb Appleton Having invested in the biotech space since before it had a name, Ive seen life sciences investors steer founders toward a therapeutics pipeline in hopes of securing the payout of a winning drug or medical device. Does the market see value in the tool today, or do you need to educate? What is your superpower?

Biotech 115

Biotech Marketing Hardware Industry 115

Crunchbase News

MAY 24, 2024

This year is shaping up as the first we’ve seen in which biotech and healthcare startups receive a majority of U.S. So far in 2024, biotech and health companies have pulled in around $5.6 The biotech sector’s comparatively strong showing comes as overall Series A dealmaking looks on track to come in a bit above last year’s totals.

Biotech 137

Biotech Healthcare Generative AI Analysis 137

TechCrunch

JULY 26, 2021

The whole human proteome may be free to browse thanks to DeepMind , but at the bleeding edge of biotech new proteins are made and tested every day, a complex and time-consuming process. If everything works as advertised, Glyphic could be the new standard in protein sequencing just as demand skyrockets in the biotech world.

Biotech 249

Biotech Off-The-Shelf Chemicals Hardware 249

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

TechCrunch

MAY 4, 2022

Previously relegated to underground communities and rave culture, drugs like ketamine, MDMA (commonly known as ecstasy) and psilocybin are now being studied to develop therapies to treat everything from PTSD to cluster headaches. But as public market sentiment fluctuates, specialized VCs seem more likely to stick around for the whole trip.

Marketing 235

Marketing Technical Review Biotech Weak Development Team 235

TechCrunch

OCTOBER 28, 2022

Reporter Dominic-Madori Davis moderated a discussion with Yin, Mike Asem (founding partner of M25), and Accel partner Rich Wong that elicited suggestions for early-stage founders who don’t live in the 415 area code and spilled the tea about “the emerging markets on their radars.”. 5 tips for launching in a crowded web3 gaming market.

Technical Review 228

Technical Review Software Review Development Team Review TDD 228

TechCrunch

OCTOBER 27, 2021

Both the food ingredients and plant-based proteins markets are poised for steady growth. The global food ingredients market is forecasted to be valued at $400 billion by 2022, while plant-based foods are in line to be a $162 billion market by 2030. The biggest thing we need to do is produce a lot of ingredients,” Hume added.

Biotech 206

Biotech Sustainability Industry Marketing 206

Crunchbase News

DECEMBER 5, 2024

The IT infrastructure company said it will use the fresh cash for M&A activities and entering new markets globally. Insider , $500M, digital marketing: Marketing tech platform Insider raised a $500 million Series E led by General Atlantic to fund its expansion in the U.S. and AI product development. billion in 2021.

Artificial Inteligence 127

Artificial Inteligence Artificial Intelligence Generative AI Biotech 127

Crunchbase News

SEPTEMBER 20, 2024

Of course, biotech and fintech were in there too. tied) Serán Bioscience , $200M, biotech : The big biotech raise this week went to Serán Bioscience. The company will use the fresh capital to support product development, including the launch of flight and rental car bookings to its platform.

Biotech 116

Biotech Travel Fintech Pharmaceuticals 116

Crunchbase News

DECEMBER 15, 2023

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. The company plans to use the tech to develop gene therapies for monogenic liver diseases and cell therapies for autoimmune diseases.

Biotech 122

Biotech Artificial Inteligence Artificial Intelligence Hotels 122

TechCrunch

AUGUST 2, 2021

Planted appeared in 2019 as a spinoff from Swiss research university ETH Zurich, where the founders developed the original technique of extruding plant proteins and water into fibrous structures similar to real meat’s. The company plans to enter several new markets over Q3 and Q4, but the U.S.

Biotech 255

Biotech Technical Review Travel Course 255

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. The money will go toward the requisite testing and paperwork involved in bringing a new drug to market based on promising leads. 2021 should be a banner year for biotech startups that make smart choices early.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. PayPal co-founder Peter Thiel invested in Unity Biotechnology , which is developing drugs to treat diseases that accompany aging. How and when to build marketing teams at deep tech companies.

Research 261

Research Biotech Nonprofit Comparison 261

TechCrunch

APRIL 13, 2022

Another important data point that connects both regions: the black market is a competitive factor. However, things are moving on the legal side of the market — it appears medical cannabis still carries most of the momentum, and it is only accelerating. Europe is largely a medical-only market right now. billion by 2026.

Marketing 246

Marketing Pharmaceuticals Research Insurance 246

TechCrunch

OCTOBER 11, 2022

The startup is attempting to position itself as being uniquely prepared to work with this market, and today it announced a $15 million seed investment on a post-money valuation of $100 million. He said he’s struggling to find women for his business development organization, but that’s something that he is actively working on.

Development 248

Development Pharmaceuticals Data Engineering Engineering 248

TechCrunch

JANUARY 3, 2023

The competition is not your market competitor or incumbent. More often, it is the investor’s set of operating heuristics, many of which are quickly influenced by market conditions. When markets start to dip, most companies hunker down and focus on surviving. Reframe the macro view. Get granular.

Healthcare 214

Healthcare Marketing Games Analysis 214

TechCrunch

JULY 26, 2021

iRocket is earmarking $50 million over the next five years for the testing and development of its reusable engines and launch vehicle. Malik pointed out that the sale of Aerojet Rocketdyne to Lockheed Martin — which is still under review by the Federal Trade Commission — is going to leave a gap in the market.

Engineering 255

Engineering Testing Biotech 3D 255

CIO

NOVEMBER 25, 2024

When I started at Novanta about five years ago, my first mission was to bring scalability to our Enterprise solutions, as well as developing a digital roadmap to modernize the technology footprint, reduce technical debt, and explore strategies to ensure that we’re growing at scale. Then I started working.

Company 183

Company Technical Advisors Engineering Biotech 183

TechCrunch

SEPTEMBER 9, 2021

Teatis will use the seed money for production and marketing in the U.S., market, where its production is located, while its next funding, a Series A, is set for next year, Takatoh added. Teatis develops a supplement for all consumers interested in low-sugar foods, as well as pre-diabetics, Takatoh said.

Development 250

Development Chemicals Marketing Groups 250

N2Growth Blog

JANUARY 10, 2024

The Importance of Executive Search and Leadership Development to the Growth of the Life Sciences Industry Ensuring that organizations have access to top talent for key leadership positions and that talent is sufficiently supported and developed is critical to the growth of the life sciences industry.

Biotech 97

Biotech Leadership Recruiting Trends 97

TechCrunch

MAY 12, 2023

If you look at the stock market, the view isn’t very good: the charts are all down and in the red, and all you can see are psychedelics companies tottering by, doing their best to impress cynical investors. The developments in Australia this year are extremely interesting and worth watching closely. Will they take the lead?”

Biotech 248

Biotech Survey Weak Development Team Systems Review 248

TechCrunch

DECEMBER 8, 2020

Boost Biomes , the Y Combinator-backed developer of microbiome-based bio-fungicides and bio-pesticides for agricultural applications, has added $2 million in funding and picked up a new strategic investor in Japan’s Universal Materials Incubator.

Biotech 168

Biotech Sustainability Applications Engineering 168

TechCrunch

SEPTEMBER 27, 2021

CEO Brian Spears has a chemical engineering background and co-founded the company, which makes meat from animal cells, in 2018 after spending 12 years developing research laboratory and industry automation. “We He expects to be able to go to market in 2022, pending approval from the U.S. Food and Drug Administration.

Culture 244

Culture Development Chemicals Sustainability 244

TechCrunch

JULY 23, 2021

Startups developing so-called deep tech often find it challenging to raise capital for various reasons. At TechCrunch Early Stage: Marketing and Fundraising, two experienced investors spoke on the subject and advised startups facing a challenging fundraising path.

Technical Advisors 254

Technical Advisors Biotech Hardware Applications 254

TechCrunch

NOVEMBER 22, 2022

million in a funding round led by Sequoia India and Southeast Asia’s Surge as it plans to expand the market for its medical imagery annotations solution. and Europe for marketing its tools. Healthtech startup RedBrick AI has raised $4.6 Artificial intelligence has become ubiquitous in clinical diagnosis.

Artificial Inteligence 234

Artificial Inteligence Artificial Intelligence Biotech 3D 234

TechCrunch

MAY 18, 2021

Thirteen went public and now have an aggregated market cap of about $15 billion, and 12 were through mergers and acquisitions. For companies that originated in academic research, UTEC supports their commercialization by helping hire crucial talent, including executive positions, business development and go-to-market strategies.

Biotech 249

Biotech Automotive Research Healthcare 249

Crunchbase News

NOVEMBER 22, 2024

The IT infrastructure company will use the fresh cash for M&A activities and entering new markets globally. Kong , $175M, enterprise software: Kong, a developer of cloud API technologies, closed $175 million in an up-round Series E led by Tiger Global and Balderton Capital that valued the company at $2 billion.

Artificial Inteligence 122

Artificial Inteligence Artificial Intelligence Biotech Generative AI 122

TechCrunch

JULY 20, 2021

Twitter Spaces: SaaS marketing with MKT1 founders Emily Kramer and Kathleen Estreich. In addition to their work with individual companies, they also run founder workshops, a job board and a marketer-led syndicate. In an increasingly hot biotech market, protecting IP is key. I hope you have a great week. Walter Thompson.

Marketing 132

Marketing Biotech Windows Company 132